Clinical trials
Phase 2 Cardiovascular Diseases trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 4 |
| 2012 | 3 |
| 2017 | 1 |
| 2022 | 1 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Cardurion Pharmaceuticals, Inc. | 2 |
| Akcea Therapeutics | 1 |
| Bayer | 1 |
| Celladon Corporation | 1 |
| Charite University, Berlin, Germany | 1 |
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| KAI Pharmaceuticals | 1 |
| Pulmovant, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 15 |
| Heart Diseases | 5 |
| Heart Failure | 5 |
| Atherosclerosis | 3 |
| Dyslipidemias | 3 |
| Hyperlipidemias | 3 |
| Lung Diseases | 2 |
| Pathologic Processes | 2 |
| Vascular Diseases | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.